vs
瑞思迈（RMD）与西联汇款（WU）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是西联汇款的1.4倍（$1.4B vs $982.7M），瑞思迈净利率更高（27.6% vs 6.6%，领先21.0%），瑞思迈同比增速更快（11.0% vs 0.0%），过去两年瑞思迈的营收复合增速更高（9.0% vs -1.9%）
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
西联汇款是总部位于美国科罗拉多州丹佛市的跨国金融服务企业，在全球范围内为个人及机构用户提供便捷的跨境汇款、支付等相关金融服务，凭借广泛的服务网点覆盖和成熟的业务体系，在跨境资金流转领域拥有较高的行业知名度。
RMD vs WU — 直观对比
营收规模更大
RMD
是对方的1.4倍
$982.7M
营收增速更快
RMD
高出11.0%
0.0%
净利率更高
RMD
高出21.0%
6.6%
两年增速更快
RMD
近两年复合增速
-1.9%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $982.7M |
| 净利润 | $392.6M | $64.7M |
| 毛利率 | 61.8% | — |
| 营业利润率 | 34.6% | 12.5% |
| 净利率 | 27.6% | 6.6% |
| 营收同比 | 11.0% | 0.0% |
| 净利润同比 | 13.9% | -47.6% |
| 每股收益（稀释后） | $2.68 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RMDWU
| Q1 26 | — | $982.7M | ||
| Q4 25 | $1.4B | $972.0M | ||
| Q3 25 | $1.3B | $985.3M | ||
| Q2 25 | $1.3B | $983.6M | ||
| Q1 25 | $1.3B | $938.7M | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | $1.2B | $993.4M | ||
| Q2 24 | $1.2B | $1.0B |
净利润RMDWU
| Q1 26 | — | $64.7M | ||
| Q4 25 | $392.6M | $114.4M | ||
| Q3 25 | $348.5M | $139.6M | ||
| Q2 25 | $379.7M | $122.1M | ||
| Q1 25 | $365.0M | $123.5M | ||
| Q4 24 | $344.6M | $385.7M | ||
| Q3 24 | $311.4M | $264.8M | ||
| Q2 24 | $292.2M | $141.0M |
毛利率RMDWU
| Q1 26 | — | — | ||
| Q4 25 | 61.8% | 33.6% | ||
| Q3 25 | 61.5% | 34.7% | ||
| Q2 25 | 60.8% | 34.6% | ||
| Q1 25 | 59.3% | 34.0% | ||
| Q4 24 | 58.6% | 35.0% | ||
| Q3 24 | 58.6% | 34.2% | ||
| Q2 24 | 58.5% | 35.0% |
营业利润率RMDWU
| Q1 26 | — | 12.5% | ||
| Q4 25 | 34.6% | 19.1% | ||
| Q3 25 | 33.4% | 20.5% | ||
| Q2 25 | 33.7% | 19.6% | ||
| Q1 25 | 33.0% | 18.9% | ||
| Q4 24 | 32.5% | 17.5% | ||
| Q3 24 | 31.6% | 16.6% | ||
| Q2 24 | 31.2% | 18.7% |
净利率RMDWU
| Q1 26 | — | 6.6% | ||
| Q4 25 | 27.6% | 11.8% | ||
| Q3 25 | 26.1% | 14.2% | ||
| Q2 25 | 28.2% | 12.4% | ||
| Q1 25 | 28.3% | 13.2% | ||
| Q4 24 | 26.9% | 37.9% | ||
| Q3 24 | 25.4% | 26.7% | ||
| Q2 24 | 23.9% | 13.8% |
每股收益（稀释后）RMDWU
| Q1 26 | — | $0.41 | ||
| Q4 25 | $2.68 | $0.36 | ||
| Q3 25 | $2.37 | $0.43 | ||
| Q2 25 | $2.58 | $0.37 | ||
| Q1 25 | $2.48 | $0.36 | ||
| Q4 24 | $2.34 | $1.14 | ||
| Q3 24 | $2.11 | $0.78 | ||
| Q2 24 | $1.97 | $0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $909.2M |
| 总债务越低越好 | $403.9M | — |
| 股东权益账面价值 | $6.3B | $910.5M |
| 总资产 | $8.5B | $8.1B |
| 负债/权益比越低杠杆越低 | 0.06× | — |
8季度趋势，按日历期对齐
现金及短期投资RMDWU
| Q1 26 | — | $909.2M | ||
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $947.8M | ||
| Q2 25 | $1.2B | $1.0B | ||
| Q1 25 | $932.7M | $1.3B | ||
| Q4 24 | $521.9M | $1.5B | ||
| Q3 24 | $426.4M | $1.1B | ||
| Q2 24 | $238.4M | $1.0B |
总债务RMDWU
| Q1 26 | — | — | ||
| Q4 25 | $403.9M | $2.9B | ||
| Q3 25 | $408.7M | $2.5B | ||
| Q2 25 | $658.4M | $2.5B | ||
| Q1 25 | $663.1M | $2.5B | ||
| Q4 24 | $662.9M | $3.0B | ||
| Q3 24 | $667.6M | $2.1B | ||
| Q2 24 | $697.3M | $2.1B |
股东权益RMDWU
| Q1 26 | — | $910.5M | ||
| Q4 25 | $6.3B | $957.8M | ||
| Q3 25 | $6.1B | $925.4M | ||
| Q2 25 | $6.0B | $883.6M | ||
| Q1 25 | $5.5B | $939.4M | ||
| Q4 24 | $5.3B | $968.9M | ||
| Q3 24 | $5.2B | $652.7M | ||
| Q2 24 | $4.9B | $440.8M |
总资产RMDWU
| Q1 26 | — | $8.1B | ||
| Q4 25 | $8.5B | $8.3B | ||
| Q3 25 | $8.3B | $7.8B | ||
| Q2 25 | $8.2B | $8.0B | ||
| Q1 25 | $7.6B | $8.3B | ||
| Q4 24 | $7.1B | $8.4B | ||
| Q3 24 | $7.2B | $7.7B | ||
| Q2 24 | $6.9B | $8.0B |
负债/权益比RMDWU
| Q1 26 | — | — | ||
| Q4 25 | 0.06× | 3.01× | ||
| Q3 25 | 0.07× | 2.70× | ||
| Q2 25 | 0.11× | 2.83× | ||
| Q1 25 | 0.12× | 2.61× | ||
| Q4 24 | 0.13× | 3.04× | ||
| Q3 24 | 0.13× | 3.29× | ||
| Q2 24 | 0.14× | 4.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $339.7M | $109.0M |
| 自由现金流经营现金流 - 资本支出 | $311.2M | — |
| 自由现金流率自由现金流/营收 | 21.9% | — |
| 资本支出强度资本支出/营收 | 2.0% | 4.8% |
| 现金转化率经营现金流/净利润 | 0.87× | 1.68× |
| 过去12个月自由现金流最近4个季度 | $1.8B | — |
8季度趋势，按日历期对齐
经营现金流RMDWU
| Q1 26 | — | $109.0M | ||
| Q4 25 | $339.7M | $135.4M | ||
| Q3 25 | $457.3M | $260.4M | ||
| Q2 25 | $538.8M | $-300.0K | ||
| Q1 25 | $578.7M | $148.2M | ||
| Q4 24 | $308.6M | $134.0M | ||
| Q3 24 | $325.5M | $212.1M | ||
| Q2 24 | $440.1M | $-33.8M |
自由现金流RMDWU
| Q1 26 | — | — | ||
| Q4 25 | $311.2M | $115.5M | ||
| Q3 25 | $414.4M | $252.7M | ||
| Q2 25 | $508.2M | $-7.8M | ||
| Q1 25 | $557.9M | $144.8M | ||
| Q4 24 | $288.0M | $119.7M | ||
| Q3 24 | $307.7M | $205.1M | ||
| Q2 24 | $415.2M | $-38.9M |
自由现金流率RMDWU
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 11.9% | ||
| Q3 25 | 31.0% | 25.6% | ||
| Q2 25 | 37.7% | -0.8% | ||
| Q1 25 | 43.2% | 15.4% | ||
| Q4 24 | 22.5% | 11.8% | ||
| Q3 24 | 25.1% | 20.6% | ||
| Q2 24 | 33.9% | -3.8% |
资本支出强度RMDWU
| Q1 26 | — | 4.8% | ||
| Q4 25 | 2.0% | 2.0% | ||
| Q3 25 | 3.2% | 0.8% | ||
| Q2 25 | 2.3% | 0.8% | ||
| Q1 25 | 1.6% | 0.4% | ||
| Q4 24 | 1.6% | 1.4% | ||
| Q3 24 | 1.5% | 0.7% | ||
| Q2 24 | 2.0% | 0.5% |
现金转化率RMDWU
| Q1 26 | — | 1.68× | ||
| Q4 25 | 0.87× | 1.18× | ||
| Q3 25 | 1.31× | 1.87× | ||
| Q2 25 | 1.42× | -0.00× | ||
| Q1 25 | 1.59× | 1.20× | ||
| Q4 24 | 0.90× | 0.35× | ||
| Q3 24 | 1.05× | 0.80× | ||
| Q2 24 | 1.51× | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
WU
暂无分部数据
